Evaluating Artisential Laparoscopic Instruments in Gynecologic Surgery
Launched by KERN MEDICAL CENTER · Sep 17, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at new tools called Artisential laparoscopic instruments to see how effective and safe they are for certain types of minimally invasive gynecologic surgeries. These surgeries include procedures like total hysterectomy (removal of the uterus) and sacrocolpopexy (a surgery to support pelvic organs). The goal is to understand if these instruments can help make the surgeries easier and safer for women.
To participate in this trial, women must be scheduled for one of the surgeries mentioned above. Unfortunately, if someone is not a candidate for these specific procedures, they would not be eligible to join the study. The trial is not yet recruiting participants, so it’s an early step in understanding how these instruments can improve surgical outcomes. If you or someone you know might be having one of these surgeries soon, this trial could be an important opportunity to explore better surgical options.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patient scheduled for robotic or laparoscopic total hysterectomy
- • Patient scheduled for robotic or laparoscopic sacrocolpopexy
- Exclusion Criteria:
- • Not a candidate for the above surgical procedures
About Kern Medical Center
Kern Medical Center is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. With a commitment to innovation and excellence, the center actively participates in clinical trials aimed at improving patient outcomes and exploring new therapeutic options. Kern Medical Center's robust infrastructure and interdisciplinary team of experienced professionals facilitate the efficient execution of diverse clinical studies, ensuring adherence to the highest ethical standards and regulatory guidelines. The center's focus on collaboration and patient-centered care makes it a pivotal player in the advancement of medical science and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported